ANNUAL M EETING EXPO - ISPE · • Quality Control, Quality Assurance (QA/QC) • RFID • Risk...
Transcript of ANNUAL M EETING EXPO - ISPE · • Quality Control, Quality Assurance (QA/QC) • RFID • Risk...
ANNUAL MEETING & EXPODEMOGRAPHIC PROFILE
Purchasing Roles
Purchasing Decision Maker
Recommend to D
ecis
ion
Mak
er
Investigate New Products/
Infl
uenc
e Pu
rcha
sing Decisio
ns
21% 29%
16% 34%Technologies/Services
1,776
31
46Total Attendees
CountriesRepresented
StatesRepresented
Plus DC and Puerto Rico
19%International Attendees
Countries with Largest AttendanceU.S., UK, Japan
and Canada
States with Largest AttendancePennsylvania, North Carolina
and Georgia
Demographic Breakdown
Primary Business:
n 29% Pharmaceutical/Biotech Manufacturer (Non-CMO)
n 25% Engineering/Architecture/Construction
n 23% Service Provider
n 10% Equipment/Material Supplier
n 4% Educational or Government
n 3% CROs/Clinical Materials/Investigational Products
n 2% Contract Manufacturer
n 2% Generics/Nutraceuticals Manufacturers
n 1% API/Excipient Supplier/Distributor
n 1% Medical Devices/Diagnostic Manufacturer
10% 13% 37% 23% 13% 4%
CEO/
Pres
iden
t/Own
er/
Gene
ral M
anag
er
Vice
Pre
siden
t/Chi
ef O
ffice
r
Dire
ctor/
Divi
sion
Mana
ger/
Seni
or M
anag
er
Mana
ger/
Secti
on H
ead/
Supe
rviso
r
Team
Lead
/Ope
rato
r/Te
chni
cian/
Staf
f
Stud
ent/
Post-
Docto
ral F
ellow
Level of Responsibility
Job Function
19% Architect/Engineer/Construction 3% Clinical Materials/Investigational Products 2% Knowledge Management 5% Operations/Plant Mechanics – Electric, Utilities, HVAC/
Facilities/Maintenance Planning 2% Other (Statistician, Health/Safety/Environmental, Retired) 3% Process Control/Automation 12% Project Management 13% QA/QC/Regulatory Compliance 8% Research and Development/Technology Transfer/Process
Development 17% Sales/Marketing 3% Student 2% Supply Chain Management/Warehouse Operations/
Logistics Planning 3% Technical Services/Product Support/Information Systems 8% Validation/Qualification/Commissioning
n Attendees Directly Involved in Their Companies’ Purchases of $100,000 or more
n Attendees Directly Involved in Their Companies’ Purchases of $1+ Million
$1-$250,000
Attendee Buying Power
Anticipated Equipment/Services Purchases in Next 12 Months
AttendeeBuyingPower
$250,000-$1M$1M-$5M$5M-$10M$10M +
Product Interest• Analytical Equipment
and Services
• Architecture/Engineering/Construction
• Biotech Systems
• Business Services
• Clean Room Equipmentand Supplies
• Clinical Supplies
• Consulting Services
• Containment Equipment
• Contract Manufacturing
• Contract Packaging
• Contract Research
• Contract Services
• Controls andAutomation-RelatedProducts
• Facility Design
• Facility Engineering andMaintenance
• Government/Non-Profit
• Human Resources
• HVAC Systems/Technologies
• Information Technology/IT Support
• Instruments and Controls
• Integrated Solutions
• Labeling, Coding,and Marking
• Laboratory Instrumentation, Supplies
• Manufacturing Software
• Medical Device &Design Equipment
• Packaging Machinery
• Packaging Materials andComponents
• PAT and Single-UseTechnologies
• Pharmaceutical RelatedSoftware
• Process Systems,Controls and Automation
• Processing andManufacturing
• Processing Machineryand Equipment
• Quality Control, QualityAssurance (QA/QC)
• RFID
• Risk Management/Knowledge Management
• Systems Integration
• Validation Servicesand Support
• Warehousing, Distribution, Logistics
• Water Systems/Products
*Data based on 2016 ISPE Annual Meeting & Exporegistration file and post-show survey data.
Time Spent Engaging with Exhibitors
n 34% greater than 4 hours
n 20 % 3–4 hoursn 33% 1–2 hours n 13% less than
1 hour
95%of Attendees SpentTime in the Expo
“We had a lot of opportunity for networking during the social events in the exhibit hall.” —2016 Annual Meeting
& Expo Attendee
Attendees that were satisfied or very satisfied
with the exhibit hall. 75%
88% of exhibitors were happy with their company’s overall exhibit experience at the 2016 ISPE Annual Meeting & Expo and 87% of exhibitors
were satisfied that their objectives for exhibiting were met.